Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease.
Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for two types of ...
View the Omvoh brand logo. About the VIVID Clinical Trial Program ... you are encouraged to report your pregnancy to Eli Lilly and Company at 1-800-545-5979. You are breastfeeding or plan to ...
View the Omvoh brand logo. About the VIVID Clinical Trial ProgramVIVID ... Omvoh® and its delivery device base are trademarks owned by Eli Lilly and Company. INDICATION AND SAFETY SUMMARYOmvoh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results